- Home
- OTRK vs DWTX Comparison
OTRK vs DWTX Comparison
Compare OTRK & DWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTRK
- DWTX
- Stock Information
- Founded
- OTRK 2003
- DWTX 2012
- Country
- OTRK United States
- DWTX United States
- Employees
- OTRK N/A
- DWTX N/A
- Industry
- OTRK Misc Health and Biotechnology Services
- DWTX
- Sector
- OTRK Health Care
- DWTX
- Exchange
- OTRK Nasdaq
- DWTX NYSE
- Market Cap
- OTRK 7.1M
- DWTX 5.9M
- IPO Year
- OTRK N/A
- DWTX N/A
- Fundamental
- Price
- OTRK $1.41
- DWTX $4.20
- Analyst Decision
- OTRK Strong Buy
- DWTX
- Analyst Count
- OTRK 1
- DWTX 0
- Target Price
- OTRK $45.00
- DWTX N/A
- AVG Volume (30 Days)
- OTRK 10.4K
- DWTX 3.1M
- Earning Date
- OTRK 05-13-2025
- DWTX 03-31-2025
- Dividend Yield
- OTRK N/A
- DWTX N/A
- EPS Growth
- OTRK N/A
- DWTX N/A
- EPS
- OTRK N/A
- DWTX N/A
- Revenue
- OTRK $11,239,000.00
- DWTX N/A
- Revenue This Year
- OTRK N/A
- DWTX N/A
- Revenue Next Year
- OTRK $48.09
- DWTX N/A
- P/E Ratio
- OTRK N/A
- DWTX N/A
- Revenue Growth
- OTRK N/A
- DWTX N/A
- 52 Week Low
- OTRK $1.27
- DWTX $1.62
- 52 Week High
- OTRK $7.65
- DWTX $29.28
- Technical
- Relative Strength Index (RSI)
- OTRK 42.78
- DWTX N/A
- Support Level
- OTRK $1.58
- DWTX N/A
- Resistance Level
- OTRK $1.56
- DWTX N/A
- Average True Range (ATR)
- OTRK 0.09
- DWTX 0.00
- MACD
- OTRK -0.01
- DWTX 0.00
- Stochastic Oscillator
- OTRK 0.00
- DWTX 0.00
About OTRK Ontrak Inc.
Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The Company's technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized care program. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.